Ferreira and coauthors [60] showed that activation of the ACE2-mediated pathways leads to a significant reduction in cardiac arrhythmias induced by ischemia/reperfusion (anti-arrhythmogenic effect) and an improvement in post-ischemic cardiac functions. The gene discussed is ACE2; the disease is cardiac rhythm disease.